Ensign Peak Advisors
SILK

Ensign Peak Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Ensign Peak Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-603,762
Closed -$9.05M – 1768
2023
Q3 		$9.05M Sell
603,762
-311,313
-34% -$6.48M 0.02% 419
2023
Q2 		$29.7M Buy
915,075
+26,972
+3% +$985K 0.06% 238
2023
Q1 		$34.8M Buy
888,103
+14,158
+2% +$693K 0.08% 214
2022
Q4 		$46.2M Buy
873,945
+234,050
+37% +$11.4M 0.1% 175
2022
Q3 		$28.8M Buy
639,895
+166,036
+35% +$7.14M 0.07% 220
2022
Q2 		$17.2M Buy
473,859
+190,913
+67% +$6.94M 0.04% 288
2022
Q1 		$11.7M Buy
282,946
+6,008
+2% +$211K 0.02% 392
2021
Q4 		$11.8M Buy
276,938
+4,406
+2% +$220K 0.02% 428
2021
Q3 		$15M Buy
272,532
+18,055
+7% +$945K 0.03% 358
2021
Q2 		$12.2M Sell
254,477
-107,733
-30% -$5.49M 0.02% 388
2021
Q1 		$18.3M Buy
362,210
+74,828
+26% +$4.16M 0.04% 326
2020
Q4 		$18.1M Sell
287,382
-768
-0.3% -$47.6K 0.04% 331
2020
Q3 		$19.4M Buy
288,150
+14,362
+5% +$784K 0.05% 310
2020
Q2 		$11.5M Buy
273,788
+127,006
+87% +$4.88M 0.03% 392
2020
Q1 		$4.62M Buy
146,782
+16,476
+13% +$660K 0.02% 528
2019
Q4 		$5.26M Buy
+130,306
New +$4.56M 0.01% 626

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ensign Peak Advisors's SILK Position: Q4 2023 in Review

Ensign Peak Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 603,762 shares — an estimated $9.05M sold.

Ensign Peak Advisors first reported a position in SILK in Q4 2019 and held it in 16 quarters. The position peaked at $46.2M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Ensign Peak Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 603,762 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $9.05M.
  • Ensign Peak Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Ensign Peak Advisors's Silk Road Medical, Inc. Common Stock position peaked at $46.2M in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Ensign Peak Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.